Literature DB >> 12507034

Antibody responses in sheep vaccinated against Staphylococcus aureus mastitis: a comparison of two experimental vaccines containing different adjuvants.

T Tollersrud1, P E Nørstebø, J P Engvik, S R Andersen, L J Reitan, A Lund.   

Abstract

A double-blind, placebo-controlled study was conducted to compare two vaccines using different adjuvants with regard to their ability to stimulate antibody production against the alpha- and beta-toxins and the exopolysaccharide of Staphylococcus aureus. The vaccines contained identical antigens, consisting of inactivated whole bacteria of two strains of S. aureus in addition to alpha- and beta-toxoid. One vaccine contained mineral oil, while the other used a water-soluble acrylic acid polymer resin (Carbopol) as adjuvant. Saline served as the placebo. One hundred and forty ewes were vaccinated twice before lambing, by subcutaneous injection with vaccine or placebo in the region of the supramammary lymph node, and were observed and sampled over a period of 6 months. The vaccine containing mineral oil as adjuvant induced significantly greater immune responses to the alpha- and beta-toxins than did the vaccine containing Carbopol. The latter vaccine induced higher levels of antibodies to exopolysaccharide. The degree of local adverse reactions did not differ between the two groups. The results indicate differences between the oil-adjuvanted and Carbopol-adjuvanted vaccines with regard to their ability to stimulate antibody production against S. aureus protein antigens in sheep.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12507034     DOI: 10.1023/a:1020960402112

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  27 in total

Review 1.  Immunological concepts of vaccine adjuvant activity.

Authors:  V E Schijns
Journal:  Curr Opin Immunol       Date:  2000-08       Impact factor: 7.486

Review 2.  Immunobiology of the mammary gland.

Authors:  L M Sordillo; K Shafer-Weaver; D DeRosa
Journal:  J Dairy Sci       Date:  1997-08       Impact factor: 4.034

3.  Stimulation of humoral antibody formation by polyanions. I. The effect of polyacrylic acid on the primary immune response in mice immunized with sheep red blood cells.

Authors:  T Diamantstein; B Wagner; I Beyse; M V Odenwald; G Schulz
Journal:  Eur J Immunol       Date:  1971-11       Impact factor: 5.532

4.  Efficacy of an Escherichia coli J5 mastitis vaccine in an experimental challenge trial.

Authors:  J S Hogan; W P Weiss; D A Todhunter; K L Smith; P S Schoenberger
Journal:  J Dairy Sci       Date:  1992-02       Impact factor: 4.034

5.  Antigenicity and immunogenicity of equine influenza vaccines containing a Carbomer adjuvant.

Authors:  J A Mumford; H Wilson; D Hannant; D M Jessett
Journal:  Epidemiol Infect       Date:  1994-04       Impact factor: 2.451

6.  Vaccination against experimental staphylococcal mastitis in dairy heifers.

Authors:  D L Watson
Journal:  Res Vet Sci       Date:  1992-11       Impact factor: 2.534

Review 7.  Adjuvants--a balance between toxicity and adjuvanticity.

Authors:  R K Gupta; E H Relyveld; E B Lindblad; B Bizzini; S Ben-Efraim; C K Gupta
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

8.  Influence of route of vaccine administration against experimental intramammary infection caused by Escherichia coli.

Authors:  G M Tomita; S C Nickerson; W E Owens; B Wren
Journal:  J Dairy Sci       Date:  1998-08       Impact factor: 4.034

9.  PURIFICATION OF STAPHYLOCOCCAL BETA-HEMOLYSIN AND ITS ACTION ON STAPHYLOCOCCAL AND STREPTOCOCCAL CELL WALLS.

Authors:  W R CHESBRO; F P HEYDRICK; R MARTINEAU; G N PERKINS
Journal:  J Bacteriol       Date:  1965-02       Impact factor: 3.490

10.  Effect of a Staphylococcus aureus bacterin on serum antibody, new infection, and mammary histology in nonlactating dairy cows.

Authors:  S C Nickerson; W E Owens; R L Boddie
Journal:  J Dairy Sci       Date:  1993-05       Impact factor: 4.034

View more
  9 in total

1.  Use of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoprotein.

Authors:  Antu K Dey; Brian Burke; Yide Sun; Karin Hartog; Jonathan L Heeney; David Montefiori; Indresh K Srivastava; Susan W Barnett
Journal:  Vaccine       Date:  2012-02-22       Impact factor: 3.641

Review 2.  Mastitis: comparative etiology and epidemiology.

Authors:  G Andres Contreras; Juan Miguel Rodríguez
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-09-27       Impact factor: 2.673

3.  Improvements to the live-attenuated Newcastle disease virus vaccine using Carbopol® 940 as a stabilizer.

Authors:  Mahmoud Mohamed Abd El-Moneam; Nada Adel Fathy; Naglaa I Ali; Heba Mohamed El Naggar
Journal:  Vet World       Date:  2020-08-19

4.  The Carbomer-Lecithin Adjuvant Adjuplex Has Potent Immunoactivating Properties and Elicits Protective Adaptive Immunity against Influenza Virus Challenge in Mice.

Authors:  Frank Wegmann; Amin E Moghaddam; Torben Schiffner; Kate H Gartlan; Timothy J Powell; Rebecca A Russell; Matthijs Baart; Emily W Carrow; Quentin J Sattentau
Journal:  Clin Vaccine Immunol       Date:  2015-07-01

5.  The antibody response in the bovine mammary gland is influenced by the adjuvant and the site of subcutaneous vaccination.

Authors:  Eveline M Boerhout; Ad P Koets; Tanja G T Mols-Vorstermans; Piet J M Nuijten; Mathieu J H Hoeijmakers; Victor P M G Rutten; Jetta J E Bijlsma
Journal:  Vet Res       Date:  2018-03-01       Impact factor: 3.683

Review 6.  Vaccine adjuvants to engage the cross-presentation pathway.

Authors:  Woojong Lee; M Suresh
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

7.  Sterile inflammation induced by Carbopol elicits robust adaptive immune responses in the absence of pathogen-associated molecular patterns.

Authors:  Kate H Gartlan; George Krashias; Frank Wegmann; William R Hillson; Erin M Scherer; Philip D Greenberg; Stephanie C Eisenbarth; Amin E Moghaddam; Quentin J Sattentau
Journal:  Vaccine       Date:  2016-03-19       Impact factor: 3.641

8.  Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus.

Authors:  Mallika Sastry; Baoshan Zhang; Man Chen; M Gordon Joyce; Wing-Pui Kong; Gwo-Yu Chuang; Kiyoon Ko; Azad Kumar; Chiara Silacci; Michelle Thom; Andres M Salazar; Davide Corti; Antonio Lanzavecchia; Geraldine Taylor; John R Mascola; Barney S Graham; Peter D Kwong
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

9.  Efficacy Evaluation of a Combined Hemorrhagic Septicemia-Mastitis Vaccine in Dairy Cows and Buffaloes.

Authors:  Ghulam Muhammad; Tariq Jamil; Imaad Rashid; Qudrat Ullah; Muhammad Saqib
Journal:  Animals (Basel)       Date:  2022-03-11       Impact factor: 2.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.